GSRX Industries Inc. Share Price Other OTC
Equities
GSRX
US36255V1070
Pharmaceuticals
Sales 2018 | 2.68 223.98 | Sales 2019 | 11 919.17 | Capitalization | 1.34M 112M |
---|---|---|---|---|---|
Net income 2018 | -16M -1.34B | Net income 2019 | -36M -3.01B | EV / Sales 2018 | 2,64,86,381 x |
Net cash position 2018 | 1.31M 110M | Net Debt 2019 | 2.27M 190M | EV / Sales 2019 | 3,28,290 x |
P/E ratio 2018 |
-4.29
x | P/E ratio 2019 |
-0.03
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 13.26% |
Managers | Title | Age | Since |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10/20/10 |
Director of Finance/CFO | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10/20/10 |
Jeff Rogers
BRD | Director/Board Member | 61 | 10/20/10 |
Shaun Dale
BRD | Director/Board Member | 47 | 23/20/23 |
1st Jan change | Capi. | |
---|---|---|
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |